Tumor targeted mesoporous silica nanoparticles functionalized with programmed death receptor ligand-1 antibody (anti-PD-L1) for combined chemo- and immunotherapy - Loganathan, Palanikumar; Magzoub, Mazin (Biophysical journal, 2022)